{
  "timestamp": "2025-12-09T07:13:21.122777",
  "agent_type": "procedure_analyzer",
  "procedure_summary": "MRI Scanner - With gadolinium contrast",
  "confidence_score": 0.75,
  "organs_analyzed": [
    {
      "organ_name": "liver",
      "affected_by_procedure": true,
      "at_risk": true,
      "risk_level": "moderate",
      "pathways_involved": [
        "elimination",
        "filtration"
      ],
      "known_recommendations": [],
      "potential_recommendations": [],
      "debunked_claims": [],
      "evidence_quality": "moderate"
    },
    {
      "organ_name": "blood_vessels",
      "affected_by_procedure": true,
      "at_risk": true,
      "risk_level": "moderate",
      "pathways_involved": [
        "elimination",
        "filtration"
      ],
      "known_recommendations": [
        "Assess renal function (eGFR) before contrast administration | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Prioritize non-contrast MRI techniques when diagnostically adequate | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "If contrast necessary: use lowest effective dose of macrocyclic GBCA | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Avoid GBCAs entirely if eGFR <30 mL/min/1.73m\u00b2 unless benefits clearly outweigh risks | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Pre-procedure renal function testing | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Adequate hydration (if not contraindicated) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Use of group II macrocyclic agents (gadobutrol, gadoterate, gadoteridol) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Consider alternative imaging modalities (CT angiography, ultrasound) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "No routine post-procedure monitoring needed for patients with normal renal function | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "For impaired renal function: clinical follow-up for NSF symptoms (rare with current protocols) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "NSF cases have dramatically decreased since 2007 with restricted GBCA use | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Long-term gadolinium retention data still emerging | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Limited head-to-head trials of different contrast agents in renally impaired populations | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Strong evidence base for NSF risk factors and prevention | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Well-established safety profile of non-contrast MRI | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Uncertainty regarding long-term effects of gadolinium retention | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Limited specification of exact clinical scenario (severity of kidney impairment, specific vascular territory) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Exact indication for vascular imaging | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Previous contrast exposure history | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Concurrent nephrotoxic medications | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Dialysis status if applicable | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation"
      ],
      "potential_recommendations": [],
      "debunked_claims": [],
      "evidence_quality": "moderate"
    },
    {
      "organ_name": "brain",
      "affected_by_procedure": true,
      "at_risk": true,
      "risk_level": "moderate",
      "pathways_involved": [
        "elimination",
        "filtration"
      ],
      "known_recommendations": [
        "**Overall Risk Level**: Appropriately classified as LOW for the general population | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Kidney Impairment Consideration**: The primary concern is nephrogenic systemic fibrosis (NSF) in patients with severe renal impairment (eGFR <30 mL/min/1.73m\u00b2), though this is now rare with modern group II macrocyclic agents | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Gadolinium Accumulation**: Brain deposition has been documented, particularly in dentate nucleus and globus pallidus, but no adverse clinical outcomes have been definitively linked to this phenomenon in patients with normal renal function | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Strong Evidence**: Safety and efficacy of brain MRI with contrast (decades of use, millions of procedures) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Moderate Evidence**: Gadolinium deposition patterns and prevalence | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Limited Evidence**: Clinical significance of gadolinium brain deposition in patients with normal renal function | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u2713 Proceed with contrast-enhanced MRI when clinically indicated | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u2713 Prefer macrocyclic agents (gadobutrol, gadoterate meglumine, gadoteridol) over linear agents | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u2713 Use lowest effective dose | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u2713 Document medical necessity in patient record | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u26a0 Assess risk-benefit ratio carefully | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u26a0 Consider non-contrast MRI sequences first (FLAIR, DWI, SWI, ASL perfusion) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u26a0 If contrast essential: use group II macrocyclic agents at lowest dose | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u26a0 Avoid repeat dosing within 7 days | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "\u26a0 Consider hemodialysis timing if patient already on dialysis (though benefit unclear) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Pregnancy**: Avoid unless absolutely necessary; gadolinium crosses placenta | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Pediatrics**: Use only when benefit clearly outweighs risk; prefer macrocyclic agents | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Multiple prior exposures**: Document cumulative exposure; consider contrast-free alternatives when feasible | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Use alternative MRI sequences that don't require contrast (advanced techniques like arterial spin labeling, susceptibility-weighted imaging) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Employ reduced-dose protocols (half-dose often adequate for many indications) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Extend intervals between contrast-enhanced studies when possible | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Substitute with non-gadolinium imaging when appropriate (CT, PET, non-contrast MRI) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation"
      ],
      "potential_recommendations": [
        "-- | Rationale: Limited but promising evidence - requires further validation | Evidence: Limited - preliminary studies | Limitations: Requires further study"
      ],
      "debunked_claims": [
        "Routine \"gadolinium detoxification\" protocols (no evidence of benefit) | Why debunked: Insufficient evidence or proven harmful | Why harmful: May delay appropriate care or cause direct harm",
        "Avoiding all gadolinium contrast due to deposition alone (risk not proportionate to benefit in indicated cases) | Why debunked: Insufficient evidence or proven harmful | Why harmful: May delay appropriate care or cause direct harm",
        "-- | Why debunked: Insufficient evidence or proven harmful | Why harmful: May delay appropriate care or cause direct harm",
        "High confidence in safety profile for standard-risk patients (extensive literature, regulatory review) | Why debunked: Insufficient evidence or proven harmful | Why harmful: May delay appropriate care or cause direct harm",
        "High confidence in NSF risk factors and prevention strategies | Why debunked: Insufficient evidence or proven harmful | Why harmful: May delay appropriate care or cause direct harm",
        "Moderate confidence regarding long-term significance of gadolinium deposition (ongoing research) | Why debunked: Insufficient evidence or proven harmful | Why harmful: May delay appropriate care or cause direct harm"
      ],
      "evidence_quality": "moderate"
    },
    {
      "organ_name": "skin",
      "affected_by_procedure": true,
      "at_risk": true,
      "risk_level": "moderate",
      "pathways_involved": [
        "elimination",
        "filtration"
      ],
      "known_recommendations": [
        "Hidradenitis suppurativa mapping | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Scleroderma tissue characterization | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Pre-surgical planning for complex reconstructions | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Monitoring response to systemic therapies in inflammatory conditions | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "No ionizing radiation exposure | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Excellent safety record for skin imaging specifically | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Non-invasive with minimal patient risk | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation"
      ],
      "potential_recommendations": [],
      "debunked_claims": [],
      "evidence_quality": "moderate"
    },
    {
      "organ_name": "kidneys",
      "affected_by_procedure": true,
      "at_risk": true,
      "risk_level": "moderate",
      "pathways_involved": [
        "elimination",
        "filtration"
      ],
      "known_recommendations": [
        "**Nephrogenic Systemic Fibrosis (NSF)**: The primary historical concern with GBCAs in kidney disease patients, particularly those with eGFR <30 mL/min/1.73m\u00b2. Risk is nearly eliminated with modern group II macrocyclic agents (gadobutrol, gadoteridol, gadoterate meglumine) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Gadolinium Retention**: Recent evidence shows tissue deposition even in patients with normal renal function, though clinical significance remains unclear | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Acute Kidney Injury**: Direct nephrotoxicity is rare but documented, particularly with older linear agents | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**eGFR >30**: Low risk with macrocyclic agents; standard protocols apply | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**eGFR 15-29**: Moderate risk; requires careful benefit-risk assessment | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**eGFR <15 or dialysis**: Higher risk; consider non-contrast alternatives first | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Use lowest effective GBCA dose (often 0.1 mmol/kg or less) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Preferentially select group II macrocyclic agents | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Ensure adequate hydration pre- and post-procedure | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Consider prophylactic hemodialysis in dialysis-dependent patients (though benefit is debated) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Evaluate if non-contrast MRI sequences (DWI, BOLD, ASL) can provide adequate diagnostic information | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Non-contrast MRI protocols increasingly viable for many kidney pathologies | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Ultrasound with Doppler for vascular assessment | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "CT with iodinated contrast (paradoxically may be safer than gadolinium in severe CKD for some indications) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Strong evidence**: NSF risk with linear agents in severe CKD | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Moderate evidence**: Safety of macrocyclic agents, gadolinium retention patterns | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Limited evidence**: Long-term clinical significance of gadolinium deposition, optimal protocols for CKD stages 3-4 | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Strengths**: Well-established guidelines for NSF prevention; clear evidence on agent selection | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Limitations**: Evolving understanding of gadolinium retention significance; variable institutional protocols; incomplete mechanism data for tissue deposition | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "**Uncertainty**: Long-term outcomes of gadolinium retention; optimal management for borderline eGFR values (30-45 range) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation"
      ],
      "potential_recommendations": [],
      "debunked_claims": [],
      "evidence_quality": "moderate"
    },
    {
      "organ_name": "lung",
      "affected_by_procedure": true,
      "at_risk": true,
      "risk_level": "moderate",
      "pathways_involved": [
        "elimination",
        "filtration"
      ],
      "known_recommendations": [
        "Lack of specific patient context (age, comorbidities, indication) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "ACR Manual on Contrast Media (latest edition) - for specific renal function thresholds and GBCA recommendations | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "European Society of Urogenital Radiology (ESUR) guidelines on contrast agents | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Recent systematic reviews on lung MRI techniques and diagnostic accuracy | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Comparative effectiveness studies: lung MRI vs. CT for specific indications | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Actual eGFR values and renal function status | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Specific clinical indication for the MRI | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Previous imaging history and radiation exposure | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Complete list of patient comorbidities | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Which specific GBCA is planned (if any) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Dosing protocols for lung imaging | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Institution-specific protocols for renal impairment | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Updated NSF incidence rates with modern GBCAs | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Gadolinium deposition studies (brain, bone) | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Long-term safety outcomes in renally impaired populations | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Comparative diagnostic yield: MRI vs. CT vs. chest X-ray for the specific indication | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation",
        "Cost-effectiveness analyses for the clinical scenario | Rationale: Evidence-based intervention - detailed rationale not parsed from text | Evidence: Strong - based on clinical guidelines | Timing: As clinically indicated | Implementation: Consult healthcare provider for specific implementation"
      ],
      "potential_recommendations": [],
      "debunked_claims": [],
      "evidence_quality": "moderate"
    }
  ],
  "general_recommendations": [
    "Consult healthcare provider",
    "Monitor for adverse effects"
  ],
  "research_gaps": [
    "Long-term gadolinium retention effects",
    "Optimal hydration protocols"
  ],
  "reasoning_steps_count": 6,
  "cost_analysis": {
    "total_cost": 0,
    "total_duration": 0,
    "phases": [],
    "most_expensive": []
  }
}